The Future of AML Treatment: What’s Next?
May 14, 2024
Topics Covered
We invite you to learn more about:
- Current and emerging treatments for acute myeloid leukemia (AML)
- Side-effects management
- Communicating effectively with your healthcare team
Program Materials
Transcript will be available soon.
Speaker
Rory Shallis, MD
Assistant Professor, Medicine (Hematology)
Yale Cancer Center and
Smilow Cancer Hospital
New Haven, CT
Program Support
Support for this program provided by AbbVie Inc. and Genentech, Inc. & Biogen.